| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/04/1997 | EP0776182A1 Therapeutic use of acetazolamide for the treatment of brain edema |
| 06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
| 06/04/1997 | EP0737211B1 Cationic biopolymers |
| 06/04/1997 | EP0697859B1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 06/04/1997 | EP0691980B1 7-deazapurine modified oligonucleotides |
| 06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
| 06/04/1997 | EP0664707B1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
| 06/04/1997 | EP0630369B1 Benzimidazole anthelmintic agents |
| 06/04/1997 | EP0621784B1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 06/04/1997 | EP0559690B1 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM |
| 06/04/1997 | EP0553278B1 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
| 06/04/1997 | EP0541617B1 1,4-disubstituted piperazines |
| 06/04/1997 | EP0491829B1 Composition for immune system activation |
| 06/04/1997 | CN1151209A Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans |
| 06/04/1997 | CN1151164A Sterol derivatives used for regulation of meiosis |
| 06/04/1997 | CN1151157A Metalloproteinase inhibitors |
| 06/04/1997 | CN1151156A Isoprenyl transferase inhibitors |
| 06/04/1997 | CN1151154A Novel antitumor and antileukemia substanes, preparation thereof and pharmaceutical compositions containing same |
| 06/04/1997 | CN1151117A Binding of E-selectin, P-selectin or L-selectin to sialyl-Lewis(x) or sialyl-lewis(a) |
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1151115A Topical compositions comprising N-acetyl-L-cysteine |
| 06/04/1997 | CN1150951A Five compounds of Qingyang ginseng glucoside and its preparation method and application |
| 06/04/1997 | CN1150950A Cephalosporin derivatives |
| 06/04/1997 | CN1150947A Alkenyl-benzoyl guanidine derivant |
| 06/04/1997 | CN1150901A Concentrated aqueous solution of rotatory enzyme inhibitor |
| 06/04/1997 | CN1035055C Process for preparaing unsaturated 17-'beta' substituted 3-carboxysteroids |
| 06/04/1997 | CN1035054C Novel isoxazolines as antiinflammatory agents |
| 06/04/1997 | CN1035039C Preparation method for dimethylamine tetracycline drug transmission system |
| 06/04/1997 | CN1035038C Preparation of pharmaceutical composition for preventing venereal disease |
| 06/03/1997 | USRE35524 Antitumor agents |
| 06/03/1997 | US5635539 Containing an oil that is not surface active or water soluble, a surfactant and water; oxygen transport agents, artificial blood, contrast agents for biological imaging |
| 06/03/1997 | US5635537 8-substituted-2-aminotetralins |
| 06/03/1997 | US5635536 Emulsion suitable for administering a sphingolipid |
| 06/03/1997 | US5635535 Ingesting propionic acid or salt and amino acid while metabolizing body fat with diet and excercise |
| 06/03/1997 | US5635534 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
| 06/03/1997 | US5635533 Antitumor agents |
| 06/03/1997 | US5635532 Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
| 06/03/1997 | US5635529 Sulfonamidodioxepanes, methods of preparation, intermediates, salts and use thereof |
| 06/03/1997 | US5635528 Intermediates to tetrahydro-beta-carbolines |
| 06/03/1997 | US5635526 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 06/03/1997 | US5635525 Benzimidazole derivatives as angiotensin II receptor antagonists, pharmacticals, and treatment of hypertension therewith |
| 06/03/1997 | US5635524 Cyclization; salt formation; separation; stimulant for beta-adrenergic receptors |
| 06/03/1997 | US5635523 Retroviral protease inhibiting compounds |
| 06/03/1997 | US5635520 Anti-ulcer compositions suitable for rectal administration |
| 06/03/1997 | US5635518 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 06/03/1997 | US5635517 Viricides |
| 06/03/1997 | US5635516 (Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents |
| 06/03/1997 | US5635515 Administering cinchonine and/or hydroquinidine |
| 06/03/1997 | US5635513 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2[(5-methyl-1H-imidazol-4yl)methyl]-1H-pyrido[4,3-b]in |
| 06/03/1997 | US5635512 Method for modifying or resetting the prolactin rhythm of an insulin insensitive or diabetic animal or human |
| 06/03/1997 | US5635511 Acid addition salt derivatives; antiarrhythmia agents; active suppression of extrasystoles, ventricular flutters and fibrillations |
| 06/03/1997 | US5635509 Asthma; bronchodilator agents; vasodilation microvascular permeability; mast cells |
| 06/03/1997 | US5635507 Pharmacologically active CNS compounds |
| 06/03/1997 | US5635504 Diazepine containing dual action inhibitors |
| 06/03/1997 | US5635503 Dihydropyridine npy antagonists: piperazine derivatives |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635501 Alphalosporins and 1-carba-1-dethia cephalosporins |
| 06/03/1997 | US5635499 Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained |
| 06/03/1997 | US5635498 Method of controlling male fertility |
| 06/03/1997 | US5635496 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 06/03/1997 | US5635495 Antiarthritic agents treating bone disorder, osteoporosis; calcium channel blockers |
| 06/03/1997 | US5635490 Administering polyether antibiotic and benzimidazole derivative |
| 06/03/1997 | US5635486 Ophthalmic composition comprising a sleep adjusting substance |
| 06/03/1997 | US5635485 Erythromycin compounds |
| 06/03/1997 | US5635382 Method for enhancing transmembrane transport of exogenous molecules |
| 06/03/1997 | US5635218 Method of treating cancer by conjunctive therapy with N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent |
| 06/03/1997 | US5635215 Hydrophilic acrylic copolymer coated with cell adhesion promoter |
| 06/03/1997 | US5635213 Pharmaceutical formulation |
| 06/03/1997 | US5635209 Mixing with a potassium iodide stabilizer, a disintegrant a lubricant and a carrier; photostability; heat resistance; humidity; shelf life |
| 06/03/1997 | US5635208 Mixing binder-wetted acetaminophen-filler-disintegrant granulation while spraying with diphenhydramine hydrochloride solution, spraying binder, drying |
| 06/03/1997 | US5635205 Carrier system including local anesthetic, amphipathic polar lipid, nonpolar lipid comprising mixture of glycerol monocaprylate and glycerol monocaprate, wherein discrete lipid particles form in aqueous medium |
| 06/03/1997 | US5635200 Having polymeric or cellulosic binder and lipid coating |
| 06/03/1997 | US5635197 Treatment and prevention of prostatic cancer metastasis |
| 06/03/1997 | US5635189 Tocopherols |
| 06/03/1997 | US5635185 Extracts of Piliostigma thonningii, the use thereof and formulations containing them |
| 06/03/1997 | US5635184 Containing tree extract mixture of a-phellandrene, b-phellandrene, carvacrol, a-pinene, and b-pinene; topical |
| 06/03/1997 | US5635172 Comprising a drug for controlling and treating ocular hypertension, an anionic mucomimetic polymer having carboxyl groups and a cation exchane resin |
| 06/03/1997 | US5635164 Stick composition with sodium chloride and stearyl alcohol |
| 06/03/1997 | US5635162 Hemostatic composition for treating gingival area |
| 06/03/1997 | US5635160 Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
| 06/03/1997 | CA2143974C Terazosin monohydrochloride and processes and intermediate for its production |
| 06/03/1997 | CA2143971C Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
| 06/03/1997 | CA2143204C Use of dideoxy nucleoside analogues in the treatment of viral infections |
| 06/03/1997 | CA2134038C Potentiation of drug response |
| 06/03/1997 | CA2107382C Terazosin polymorph and pharmaceutical composition |
| 06/03/1997 | CA2098199C Psyllium and cholestyramine compositions with improved palatability |
| 06/03/1997 | CA2040517C 1,8-naphthyridin-2-one derivatives |
| 06/03/1997 | CA2004350C Propenone oxime ethers, a method of preparing them, and pharmaceutical compositions containing them |
| 05/29/1997 | WO1997019194A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
| 05/29/1997 | WO1997019186A1 Antifungal substances be-49385 and process for producing the same |
| 05/29/1997 | WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019173A1 Method of treating sepsis |
| 05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019107A1 Identification of antigenes from post-infection nematodes for the purpose of developing new anthelmintics and vaccines |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019102A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | WO1997019097A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | WO1997019095A1 6-0-methyl erythromycin d and process for making |